Tests a functional and cognitive rehabilitation program for adults with long Covid-19
Compares rehabilitation exercises with informational messages in adults with long Covid-19 and chronic diseases.
Plain-language title generated from the registry record
Registry title: Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
Key facts
- Where
- Bogotá, ColombiaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06871293, who can take part
Where in Colombia
- Fundación Cardioinfantil-Instituto de cardiologíaBogotá, ColombiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fundación Cardioinfantil Instituto de Cardiología
- Trial code
- NCT06871293
- Record updated
- 13 April 2026
- Original description
This study aims to evaluate the impact of a functional and cognitive rehabilitation strategy compared to evidence-based informational messages, on functional capacity, cognitive abilities, quality of life, and disease progression in adults with chronic non-communicable diseases (NCDs) and Long Covid-19.Read full original descriptionShow less
Impact of Functional and Cognitive Rehabilitation, in Adults With Chronic Noncommunicable Diseases and Long Covid-19 , on Their Functional and Cognitive Capacity, Quality of Life, and the Evolution of Their Baseline Condition, in Bogotá D.C.
This study aims to evaluate the impact of a functional and cognitive rehabilitation strategy compared to evidence-based informational messages, on functional capacity, cognitive abilities, quality of life, and disease progression in adults with chronic non-communicable diseases (NCDs) and Long Covid-19.
Researchers will compare a structured rehabilitation program to informational support through evidence-based messages to determine if rehabilitation leads to better functional and cognitive outcomes in patients with Long Covid-19.
Participants will be randomly assigned to one of two groups:
1. Functional and cognitive rehabilitation: Attending weekly in-person sessions for 8 weeks, including supervised physical and cognitive exercises. 2. Informational support: Receiving weekly evidence-based educational messages for 8 weeks.
Participants will undergo assessments at baseline, post-intervention, and six months later, including a six-minute walk test, handgrip strength measurement, and questionnaires on disability, anxiety, depression, fatigue, dyspnea, cognitive function, and quality of life.
Inclusion: Covid-19 confirmed; History of arterial hypertension or diabetes mellitus before entering the institutional registries of the FCI-IC or HOMIL, institutional registries of the FCI-IC or HOMIL or before having the diagnosis of SARSCoV-2 infection; Persistence of two or more concurrent symptoms, related to Covid-19 prologue, for at least 4 weeks (persistent, intermittent, or intermittent); At least one of these symptoms must have an impact on activities of daily living. They can be physical (fatigue, dyspnea, myalgias, arthralgias) or neuropsychiatric (cognitive, sleep and emotional alterations); Symptoms unexplained by underlying disease or other condition concomitant with SARS-CoV-2 infection. SARS-CoV-2 infection (determined by prior medical history review and participant interview); participant interview); Ability to read and attend functional and cognitive rehabilitation sessions or to receive the with evidence-based informational messages.
Exclusion: Severely advanced baseline comorbidities prior to SARS-CoV-2 infection; Two hospitalizations in the year prior to admission to the institutional registries of the FCI-IC and the HOMIL for the patient's underlying disease; Presence of chronic respiratory disease (partial or permanent supplemental oxygen use), cardiac failure (LVEF<40%) or advanced renal disease (GFR<30%); heart failure (LVEF<40%) or advanced renal disease (GFR<30); Age >80 years; Dependence on a caregiver; Orthopedic or cardiopulmonary problems that contraindicate the performance of aerobic exercise; Neuropsychiatric or cognitive limitations that limit understanding or following commands and performing attention exercises.